The final set of Molecules of the Month for 2022 is out, and now it’s time to nominate your favorite molecules for 2022’s Molecules of the Year!
Nominees should have either been first disclosed in 2022 or had a major new update in 2022 (e.g. clinical trial readout, publication, business transaction, approval). The molecule must have a published structure and ideally a publication describing its properties or discovery campaign.
Clinical candidates with interesting profiles, non-clinical molecules with intriguing modes of action, and recently approved drugs can all be nominated. You can nominate your own company’s molecule, but you just can’t vote for it in the final selection.
Most importantly, have fun thinking about it! It’s a great time to reflect on what’s inspired us, and how amazing the science in this industry is.
Check out the past winners here:
- 2021 Molecule of the Year: Pfizer’s CoV-2 Mpro Inhibitor, Paxlovid
- 2020 Molecule of the Year: Gilead’s HIV capsid inhibitor, lenacapavir
And past nominees here:
For even more inspiration, browse the collection of 120 molecules of the month from 2022 here.
